Navigation Links
MaxWell Biocorporation, LLC, and International Medical Information Technologies, Inc., Announce Partnership
Date:8/1/2008

- Sponsorship Agreement Promotes International Medical Education, Helps

Break Down Language Barrier -

WASHINGTON, Aug. 1 /PRNewswire/ -- Russian-speaking medical professionals around the world have a potent new ally to help them integrate into the English-speaking mainstream of global medical research.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080624/NETU078LOGO )

Dr. Peter M. Leitner, President of MaxWell USA, LLC, and Dr. Marina Filshtinsky, President of Boston-based International Medical Information Technologies, Inc. (IMIT) and editor-in-chief of MedMir.com, announced today a sponsorship deal between their two organizations.

MaxWell USA will provide the first significant outside funding received by IMIT since its 2005 inception. As a result, IMIT will be in a stronger position to supply timely, comprehensive, and free translations of leading medical journal articles to Russian-speaking medical professionals around the world.

By partnering, MaxWell and IMIT will contribute more effectively to improving the quality of healthcare offered by Russian-speaking medical providers to their patients wherever they may be.

About MedMir

MedMir.com (http://www.medmir.com) is the first project of the Boston-based nonprofit organization International Medical Information Technologies, Inc., IMIT (http://www.imithome.org). MedMir provides Russian-speaking medical professionals around the world with free access to timely, comprehensive, and accurate summaries of leading research papers from the world's top medical journals, translated by highly qualified medical specialists. The MedMir project began in January 2005 and has consistently attracted a growing number of Russian-speaking medical professional visitors to its website. MedMir is the only service on the Internet that provides timely, comprehensive international medical information in Russian. MedMir.com = World Medical Journal Reviews In Russian.

About MaxWell

MaxWell Biocorporation (http://www.max-well.com) is a U.S.-based, privately-held international medical and pharmaceutical company with wholly owned subsidiaries and affiliates in the United States and Ukraine dedicated to increasing life expectancy and improving the quality of life of people in Ukraine and other underserved emerging healthcare markets in the former Soviet Union. MaxWell targets oncological, cardiological, chronic infectious and autoimmune disorders and diseases through the development, production, and introduction into clinical practice of sophisticated, high quality, and affordable off-patent generic biopharmaceutical and chemopharmaceutical medicines and the latest diagnostic and therapeutic methods. MaxWell = "Maximum Wellness."

"We Help You Live Longer"

Contact:

Alex Meerovich

A.Meerovich@max-well.com

202-454-3403 Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Kenneth Alibek https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78826 Peter Leitner https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78827


'/>"/>
SOURCE MaxWell Biocorporation, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. U.S. Commerce Secretary Gutierrez Cuts Ribbon on MaxWell Biocorporations New Pharmaceutical Development Center and Quality Control Laboratory in Ukraine
2. PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant
3. Geecf: Spectrum Blue Steel Announces Strategic Partnership with Al Manhal International Group of Abu Dhabi to Deploy Biosphere Facilities
4. Pharmasmart International Taps Top Executive Ashton Maaraba to Head Global Sales and Marketing
5. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
6. Ardea to Present Data on Lead HIV Candidate, RDEA806, at XVII International AIDS Conference
7. Cryo-Cell International, Inc. Reports Second Quarter 2008 Results
8. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
9. Access Pharmaceuticals Presents New Data at International Symposium Showing Companys Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
10. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
11. PAREXEL International Updates Earnings Guidance in Conjunction with Its Investor Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Cell therapies for a range ... by research at Worcester Polytechnic Institute (WPI) that yielded a newly patented method ... , The novel method, developed by WPI faculty members Raymond Page, PhD, professor ...
(Date:5/23/2016)... ... ... blood donations in South Texas and across the nation is growing. , But according to ... are on the decline. In fact, donations across the country are at their lowest point ... the last four years alone. , There is no substitute for blood. , “We want ...
(Date:5/23/2016)... and LONDON , May 23, 2016 /PRNewswire/ ... See Frontage Boost Efficiency by 40% - Frontage Implement ... - Frontage Enforce Quality, Compliance and Traceability Within the Bioanalytical lab ... labs in the United States and ... to be deployed across its laboratory facilities. In addition to serving ...
(Date:5/20/2016)... ... May 20, 2016 , ... The leading Regenerative Veterinary Medicine Company, VetStem ... have treated over 100 of their own patients with the VetStem Cell Therapy. Each ... of care for their patients. , The veterinarians are Dr Ross Rich former ...
Breaking Biology Technology:
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):